Quick Answer
ASSEMBLY BIOSCIENCES, INC. reported Research And Development Expense of $64.81 million for the year ending 2025.
- ASSEMBLY BIOSCIENCES, INC. showed an increase of +15.9% in Research And Development Expense from 2024 to 2025.
- This data is from ASSEMBLY BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), ASSEMBLY BIOSCIENCES, INC.'s Research And Development Expense has grown by 2,102.3%.
- Historical annual values: Fiscal year 2025: $64.81 million | Fiscal year 2024: $55.93 million | Fiscal year 2023: $48.90 million | Fiscal year 2022: $69.98 million | Fiscal year 2021: $68.52 million | Fiscal year 2020: $106.82 million | Fiscal year 2019: $85.76 million | Fiscal year 2018: $72.74 million | Fiscal year 2017: $44.23 million | Fiscal year 2016: $33.09 million | Fiscal year 2015: $18.36 million | Fiscal year 2014: $10.72 million | Fiscal year 2013: $4.58 million | Fiscal year 2012: $19.51 million | Fiscal year 2011: $25.28 million | Fiscal year 2010: $1.85 million | Fiscal year 2009: $2.94 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: